Today: 19 May 2026
Lynas share price: what to watch after a late-Friday filing before ASX trade resumes
25 January 2026
1 min read

Lynas share price: what to watch after a late-Friday filing before ASX trade resumes

Sydney, Jan 25, 2026, 17:23 AEDT — Market closed

  • After Friday’s close, Lynas will pause trading for an extended break as the ASX remains closed Monday in observance of Australia Day
  • A late Friday filing revealed a shift in a major stake in the rare earths producer
  • After a sharp move this month, investors are zeroing in on production stability and rare-earth prices

Lynas Rare Earths Ltd shares (ASX:LYC) closed Friday at A$16.86, marking a 0.66% gain following a choppy session that saw prices fluctuate between A$17.79 and A$16.77.

Timing is key. Australia’s primary exchange shuts Monday for Australia Day, extending the pause until the next session. Investors will have extra time to digest filings and sector updates ahead of trading.

Late Friday, an exchange notice revealed a “change in substantial holding” for Lynas filed after the market closed. In Australia, a “substantial holder” typically means an investor owning 5% or more of a company’s shares, and any changes must be reported. Australian Securities Exchange

The filing follows Lynas’ December-quarter update earlier this week, which highlighted a mixed picture: better sales and pricing, but some operational setbacks. The company reported quarterly gross sales revenue of A$201.9 million and total rare earth oxide (REO) output at 2,382 tonnes, including 1,404 tonnes of NdPr (neodymium-praseodymium, a key magnet material for EVs and wind turbines). Lynas closed the quarter with A$1.03 billion in cash and short-term deposits. It also revealed plans to explore off-grid power solutions after disruptions at its Kalgoorlie plant impacted production.

Lynas’s recent surge offers a snapshot of investor sentiment on non-China supply. It also raises the question: do tougher operating conditions push prices up, or simply drive costs higher?

Management turnover remains a quiet concern. CEO and managing director Amanda Lacaze is set to retire at the end of the financial year, the company confirmed, with the board already conducting a search for her replacement.

Sell-side opinions remain mixed. According to TipRanks data from Friday, Bell Potter stuck with a “sell” rating but nudged its price target up to A$11.15 — still about 34% under Friday’s closing price. TipRanks

The debate heats up around that gap. Bulls point to the strategic angle and potential upside if NdPr pricing surprises on the high side. Bears, however, repeatedly flag execution risks and fret over what could unfold if prices slip even slightly.

The downside is clear-cut: additional power outages in Western Australia, a sluggish rebound at the Malaysian facility post-maintenance, or hold-ups in growth projects could drag volumes down and push the market toward a steeper cost structure.

The market was closed Monday, so all eyes turn to Tuesday’s reopening. Investors will be watching closely to see if the late-Friday holding notice signals normal register shifts or if big players are making significant moves in or out of Lynas at these prices.

Stock Market Today

  • Wall Street Falls on Rising Oil Prices, Iran Concerns; Dow Drops 1.1%
    May 19, 2026, 6:07 AM EDT. Wall Street closed lower on May 18 as rising oil prices surged 3.4% to $109 a barrel and geopolitical tensions with Iran increased. The Dow Jones Industrial Average fell 1.1% to 49,526.17, led by a 4.4% drop in NVIDIA shares. The tech-heavy Nasdaq declined 1.5%, while the S&P 500 lost 1.2%. Defensive sectors like Energy rose as others, including Materials and Utilities, fell. The CBOE Volatility Index jumped 6.8%, signaling increased market fear. Industrial production surprised with a 0.7% April gain, and the NY Empire State Manufacturing Index surged to 19.6, pointing to robust manufacturing activity despite global tensions.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Goldman Sachs stock slides into Fed week after CEO pay disclosure
Previous Story

Goldman Sachs stock slides into Fed week after CEO pay disclosure

Compass Group share price hits 52-week low; investors eye Feb. 5 update and dividend date
Next Story

Compass Group share price hits 52-week low; investors eye Feb. 5 update and dividend date

Go toTop